02 Oct2015
‘Gene therapy pipeline in oncology is rich but at early stage’
There are 266 pipeline gene therapies in active development for oncology, more than double that of central nervous system disorders, says GBI Research
Gene therapy pipeline in oncology gets strong
Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development across all stages, highlights analysis firm GBI Research.
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization collaboration agreement with Teijin Pharma Limited, Tokyo, Japan.